Oral Tofacitinib in Moderate and Severe Alopecia Areata: Case Series of 14 Patients
March 2023
in “
PARIPEX INDIAN JOURNAL OF RESEARCH
”
Studysummary This study found that prolonged tofacitinib treatment in adult Indian patients with moderate-to-severe alopecia areata was associated with a high regrowth rate, which varied with factors like age at disease onset and treatment duration.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →